SEC Info℠  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Actinium Pharmaceuticals, Inc. – ‘10-K’ for 12/31/18 – ‘XML’

On:  Friday, 3/15/19, at 5:02pm ET   ·   For:  12/31/18   ·   Accession #:  1213900-19-4269   ·   File #:  1-36374

Previous ‘10-K’:  ‘10-K’ on 3/16/18 for 12/31/17   ·   Next:  ‘10-K’ on 5/8/20 for 12/31/19   ·   Latest:  ‘10-K’ on 3/29/24 for 12/31/23   ·   21 References:   

Find Words in Filings emoji
 		  in    Show  and   ↓Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/15/19  Actinium Pharmaceuticals, Inc.    10-K       12/31/18   63:5.1M                                   Edgar Agents LLC/FA

Annual Report   —   Form 10-K   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML    706K 
 2: EX-3.7      Certificate of Amendment to Actinium's Certificate  HTML     17K 
                of Incorporation                                                 
 3: EX-10.37    Consulting Agreement, Dated December 21, 2018,      HTML     63K 
                Between Actinium Pharmaceuticals, Inc. and Nitya                 
                Ray                                                              
 4: EX-10.38    Amended and Restated at Market Issuance Sales       HTML    237K 
                Agreement, Dated December 28, 2018, by and Among                 
                Actinium Pharmaceuticals, Inc. and B. Riley Fbr,                 
                Inc. and Jonestrading Institutional Services LLC                 
 5: EX-10.39    Seventh Amendment to the 2013 Amended and Restated  HTML     21K 
                Stock Plan, as Amended                                           
 6: EX-23.1     Consent of Gbh CPAs, Pc.                            HTML     18K 
 7: EX-23.2     Consent of Marcum LLP.                              HTML     18K 
 8: EX-31.1     Certification -- §302 - SOA'02                      HTML     25K 
 9: EX-31.2     Certification -- §302 - SOA'02                      HTML     25K 
10: EX-32.1     Certification -- §906 - SOA'02                      HTML     19K 
11: EX-32.2     Certification -- §906 - SOA'02                      HTML     19K 
18: R1          Document and Entity Information                     HTML     56K 
19: R2          Consolidated Balance Sheets                         HTML     88K 
20: R3          Consolidated Balance Sheets (Parenthetical)         HTML     41K 
21: R4          Consolidated Statements of Operations               HTML     52K 
22: R5          Consolidated Statement of Changes in Stockholders'  HTML     72K 
                Equity                                                           
23: R6          Consolidated Statements of Cash Flows               HTML     93K 
24: R7          Description of Business and Summary of Significant  HTML     60K 
                Accounting Policies                                              
25: R8          Derivative Liabilities                              HTML     34K 
26: R9          Prepaid Expenses and Other Current Assets           HTML     24K 
27: R10         Property and Equipment                              HTML     30K 
28: R11         Commitments and Contingencies                       HTML     35K 
29: R12         Equity                                              HTML     79K 
30: R13         Income Taxes                                        HTML     43K 
31: R14         Subsequent Event                                    HTML     24K 
32: R15         Description of Business and Summary of Significant  HTML    105K 
                Accounting Policies (Policies)                                   
33: R16         Description of Business and Summary of Significant  HTML     36K 
                Accounting Policies (Tables)                                     
34: R17         Derivative Liabilities (Tables)                     HTML     34K 
35: R18         Prepaid Expenses and Other Current Assets (Tables)  HTML     24K 
36: R19         Property and Equipment (Tables)                     HTML     29K 
37: R20         Commitments and Contingencies (Tables)              HTML     23K 
38: R21         Equity (Tables)                                     HTML     48K 
39: R22         Income Taxes (Tables)                               HTML     40K 
40: R23         Description of Business and Summary of Significant  HTML     27K 
                Accounting Policies (Details)                                    
41: R24         Description of Business and Summary of Significant  HTML     23K 
                Accounting Policies (Details 1)                                  
42: R25         Description of Business and Summary of Significant  HTML     33K 
                Accounting Policies (Details 2)                                  
43: R26         Description of Business and Summary of Significant  HTML     53K 
                Accounting Policies (Details Textual)                            
44: R27         Derivative Liabilities (Details)                    HTML     25K 
45: R28         Derivative Liabilities (Details 1)                  HTML     40K 
46: R29         Derivative Liabilities (Details Textual)            HTML     33K 
47: R30         Prepaid Expenses and Other Current Assets           HTML     30K 
                (Details)                                                        
48: R31         Prepaid Expenses and Other Current Assets (Details  HTML     21K 
                Textual)                                                         
49: R32         Property and Equipment (Details)                    HTML     39K 
50: R33         Property and Equipment (Details 1)                  HTML     24K 
51: R34         Property and Equipment (Details Textual)            HTML     23K 
52: R35         Commitments and Contingencies (Details)             HTML     33K 
53: R36         Commitments and Contingencies (Details Textual)     HTML     68K 
54: R37         Equity (Details)                                    HTML     66K 
55: R38         Equity (Details 1)                                  HTML     69K 
56: R39         Equity (Details Textual)                            HTML    360K 
57: R40         Income Taxes (Details)                              HTML     35K 
58: R41         Income Taxes (Details 1)                            HTML     75K 
59: R42         Income Taxes (Details Textual)                      HTML     42K 
60: R43         Subsequent Event (Details)                          HTML     47K 
62: XML         IDEA XML File -- Filing Summary                      XML    102K 
61: EXCEL       IDEA Workbook of Financial Reports                  XLSX     60K 
12: EX-101.INS  XBRL Instance -- atnm-20181231                       XML   1.01M 
14: EX-101.CAL  XBRL Calculations -- atnm-20181231_cal               XML    103K 
15: EX-101.DEF  XBRL Definitions -- atnm-20181231_def                XML    479K 
16: EX-101.LAB  XBRL Labels -- atnm-20181231_lab                     XML    835K 
17: EX-101.PRE  XBRL Presentations -- atnm-20181231_pre              XML    674K 
13: EX-101.SCH  XBRL Schema -- atnm-20181231                         XSD    134K 
63: ZIP         XBRL Zipped Folder -- 0001213900-19-004269-xbrl      Zip    107K

‘XML’   —   IDEA XML File — Filing Summary

This Document is an IDEA XML File.

                                                                                                                                                                                
<?xml version="1.0" encoding="windows-1252"?>
<FilingSummary>
<Version> 3.19.1 </Version>
<ProcessingTime/>
<ReportFormat> html </ReportFormat>
<ContextCount> 184 </ContextCount>
<ElementCount> 270 </ElementCount>
<EntityCount> 1 </EntityCount>
<FootnotesReported> true </FootnotesReported>
<SegmentCount> 50 </SegmentCount>
<ScenarioCount> 0 </ScenarioCount>
<TuplesReported> false </TuplesReported>
<UnitCount> 4 </UnitCount>
<MyReports>
<Report instance="atnm-20181231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R1.htm </HtmlFileName>
<LongName> 00000001 - Document - Document and Entity Information </LongName>
<ReportType> Sheet </ReportType>
<Role> http://actiniumpharmaceuticals.com/role/DocumentAndEntityInformation </Role>
<ShortName> Document and Entity Information </ShortName>
<MenuCategory> Cover </MenuCategory>
<Position> 1 </Position>
</Report>
<Report instance="atnm-20181231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R2.htm </HtmlFileName>
<LongName> 00000002 - Statement - Consolidated Balance Sheets </LongName>
<ReportType> Sheet </ReportType>
<Role> http://actiniumpharmaceuticals.com/role/BalanceSheets </Role>
<ShortName> Consolidated Balance Sheets </ShortName>
<MenuCategory> Statements </MenuCategory>
<Position> 2 </Position>
</Report>
<Report instance="atnm-20181231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R3.htm </HtmlFileName>
<LongName> 00000003 - Statement - Consolidated Balance Sheets (Parenthetical) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://actiniumpharmaceuticals.com/role/BalanceSheetsParenthetical </Role>
<ShortName> Consolidated Balance Sheets (Parenthetical) </ShortName>
<MenuCategory> Statements </MenuCategory>
<Position> 3 </Position>
</Report>
<Report instance="atnm-20181231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R4.htm </HtmlFileName>
<LongName> 00000004 - Statement - Consolidated Statements of Operations </LongName>
<ReportType> Sheet </ReportType>
<Role> http://actiniumpharmaceuticals.com/role/StatementsOfOperations </Role>
<ShortName> Consolidated Statements of Operations </ShortName>
<MenuCategory> Statements </MenuCategory>
<Position> 4 </Position>
</Report>
<Report instance="atnm-20181231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R5.htm </HtmlFileName>
<LongName> 00000005 - Statement - Consolidated Statement of Changes in Stockholders' Equity </LongName>
<ReportType> Sheet </ReportType>
<Role> http://actiniumpharmaceuticals.com/role/StatementOfChangesInStockholdersEquity </Role>
<ShortName> Consolidated Statement of Changes in Stockholders' Equity </ShortName>
<MenuCategory> Statements </MenuCategory>
<Position> 5 </Position>
</Report>
<Report instance="atnm-20181231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R6.htm </HtmlFileName>
<LongName> 00000006 - Statement - Consolidated Statements of Cash Flows </LongName>
<ReportType> Sheet </ReportType>
<Role> http://actiniumpharmaceuticals.com/role/StatementsOfCashFlows </Role>
<ShortName> Consolidated Statements of Cash Flows </ShortName>
<MenuCategory> Statements </MenuCategory>
<Position> 6 </Position>
</Report>
<Report instance="atnm-20181231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R7.htm </HtmlFileName>
<LongName> 00000007 - Disclosure - Description of Business and Summary of Significant Accounting Policies </LongName>
<ReportType> Sheet </ReportType>
<Role> http://actiniumpharmaceuticals.com/role/DescriptionOfBusinessAndSummaryOfSignificantAccountingPolicies </Role>
<ShortName> Description of Business and Summary of Significant Accounting Policies </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 7 </Position>
</Report>
<Report instance="atnm-20181231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R8.htm </HtmlFileName>
<LongName> 00000008 - Disclosure - Derivative Liabilities </LongName>
<ReportType> Sheet </ReportType>
<Role> http://actiniumpharmaceuticals.com/role/DerivativeLiabilities </Role>
<ShortName> Derivative Liabilities </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 8 </Position>
</Report>
<Report instance="atnm-20181231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R9.htm </HtmlFileName>
<LongName> 00000009 - Disclosure - Prepaid Expenses and Other Current Assets </LongName>
<ReportType> Sheet </ReportType>
<Role> http://actiniumpharmaceuticals.com/role/PrepaidExpensesAndOtherCurrentAssets </Role>
<ShortName> Prepaid Expenses and Other Current Assets </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 9 </Position>
</Report>
<Report instance="atnm-20181231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R10.htm </HtmlFileName>
<LongName> 00000010 - Disclosure - Property and Equipment </LongName>
<ReportType> Sheet </ReportType>
<Role> http://actiniumpharmaceuticals.com/role/PropertyAndEquipment </Role>
<ShortName> Property and Equipment </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 10 </Position>
</Report>
<Report instance="atnm-20181231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R11.htm </HtmlFileName>
<LongName> 00000011 - Disclosure - Commitments and Contingencies </LongName>
<ReportType> Sheet </ReportType>
<Role> http://actiniumpharmaceuticals.com/role/CommitmentsAndContingencies </Role>
<ShortName> Commitments and Contingencies </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 11 </Position>
</Report>
<Report instance="atnm-20181231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R12.htm </HtmlFileName>
<LongName> 00000012 - Disclosure - Equity </LongName>
<ReportType> Sheet </ReportType>
<Role> http://actiniumpharmaceuticals.com/role/Equity </Role>
<ShortName> Equity </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 12 </Position>
</Report>
<Report instance="atnm-20181231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R13.htm </HtmlFileName>
<LongName> 00000013 - Disclosure - Income Taxes </LongName>
<ReportType> Sheet </ReportType>
<Role> http://actiniumpharmaceuticals.com/role/IncomeTaxes </Role>
<ShortName> Income Taxes </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 13 </Position>
</Report>
<Report instance="atnm-20181231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R14.htm </HtmlFileName>
<LongName> 00000014 - Disclosure - Subsequent Event </LongName>
<ReportType> Sheet </ReportType>
<Role> http://actiniumpharmaceuticals.com/role/SubsequentEvent </Role>
<ShortName> Subsequent Event </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 14 </Position>
</Report>
<Report instance="atnm-20181231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R15.htm </HtmlFileName>
<LongName> 00000015 - Disclosure - Description of Business and Summary of Significant Accounting Policies (Policies) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://actiniumpharmaceuticals.com/role/DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesPolicies </Role>
<ShortName> Description of Business and Summary of Significant Accounting Policies (Policies) </ShortName>
<MenuCategory> Policies </MenuCategory>
<ParentRole> http://actiniumpharmaceuticals.com/role/DescriptionOfBusinessAndSummaryOfSignificantAccountingPolicies </ParentRole>
<Position> 15 </Position>
</Report>
<Report instance="atnm-20181231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R16.htm </HtmlFileName>
<LongName> 00000016 - Disclosure - Description of Business and Summary of Significant Accounting Policies (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://actiniumpharmaceuticals.com/role/DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesTables </Role>
<ShortName> Description of Business and Summary of Significant Accounting Policies (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://actiniumpharmaceuticals.com/role/DescriptionOfBusinessAndSummaryOfSignificantAccountingPolicies </ParentRole>
<Position> 16 </Position>
</Report>
<Report instance="atnm-20181231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R17.htm </HtmlFileName>
<LongName> 00000017 - Disclosure - Derivative Liabilities (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://actiniumpharmaceuticals.com/role/DerivativeLiabilitiesTables </Role>
<ShortName> Derivative Liabilities (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://actiniumpharmaceuticals.com/role/DerivativeLiabilities </ParentRole>
<Position> 17 </Position>
</Report>
<Report instance="atnm-20181231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R18.htm </HtmlFileName>
<LongName> 00000018 - Disclosure - Prepaid Expenses and Other Current Assets (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://actiniumpharmaceuticals.com/role/PrepaidExpensesAndOtherCurrentAssetsTables </Role>
<ShortName> Prepaid Expenses and Other Current Assets (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://actiniumpharmaceuticals.com/role/PrepaidExpensesAndOtherCurrentAssets </ParentRole>
<Position> 18 </Position>
</Report>
<Report instance="atnm-20181231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R19.htm </HtmlFileName>
<LongName> 00000019 - Disclosure - Property and Equipment (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://actiniumpharmaceuticals.com/role/PropertyAndEquipmentTables </Role>
<ShortName> Property and Equipment (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://actiniumpharmaceuticals.com/role/PropertyAndEquipment </ParentRole>
<Position> 19 </Position>
</Report>
<Report instance="atnm-20181231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R20.htm </HtmlFileName>
<LongName> 00000020 - Disclosure - Commitments and Contingencies (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://actiniumpharmaceuticals.com/role/CommitmentsAndContingenciesTables </Role>
<ShortName> Commitments and Contingencies (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://actiniumpharmaceuticals.com/role/CommitmentsAndContingencies </ParentRole>
<Position> 20 </Position>
</Report>
<Report instance="atnm-20181231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R21.htm </HtmlFileName>
<LongName> 00000021 - Disclosure - Equity (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://actiniumpharmaceuticals.com/role/EquityTables </Role>
<ShortName> Equity (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://actiniumpharmaceuticals.com/role/Equity </ParentRole>
<Position> 21 </Position>
</Report>
<Report instance="atnm-20181231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R22.htm </HtmlFileName>
<LongName> 00000022 - Disclosure - Income Taxes (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://actiniumpharmaceuticals.com/role/IncomeTaxesTables </Role>
<ShortName> Income Taxes (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://actiniumpharmaceuticals.com/role/IncomeTaxes </ParentRole>
<Position> 22 </Position>
</Report>
<Report instance="atnm-20181231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R23.htm </HtmlFileName>
<LongName> 00000023 - Disclosure - Description of Business and Summary of Significant Accounting Policies (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://actiniumpharmaceuticals.com/role/DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesDetails </Role>
<ShortName> Description of Business and Summary of Significant Accounting Policies (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://actiniumpharmaceuticals.com/role/DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesTables </ParentRole>
<Position> 23 </Position>
</Report>
<Report instance="atnm-20181231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R24.htm </HtmlFileName>
<LongName> 00000024 - Disclosure - Description of Business and Summary of Significant Accounting Policies (Details 1) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://actiniumpharmaceuticals.com/role/DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesDetails1 </Role>
<ShortName> Description of Business and Summary of Significant Accounting Policies (Details 1) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://actiniumpharmaceuticals.com/role/DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesTables </ParentRole>
<Position> 24 </Position>
</Report>
<Report instance="atnm-20181231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R25.htm </HtmlFileName>
<LongName> 00000025 - Disclosure - Description of Business and Summary of Significant Accounting Policies (Details 2) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://actiniumpharmaceuticals.com/role/DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesDetails2 </Role>
<ShortName> Description of Business and Summary of Significant Accounting Policies (Details 2) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://actiniumpharmaceuticals.com/role/DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesTables </ParentRole>
<Position> 25 </Position>
</Report>
<Report instance="atnm-20181231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R26.htm </HtmlFileName>
<LongName> 00000026 - Disclosure - Description of Business and Summary of Significant Accounting Policies (Details Textual) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://actiniumpharmaceuticals.com/role/DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesDetailsTextual </Role>
<ShortName> Description of Business and Summary of Significant Accounting Policies (Details Textual) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://actiniumpharmaceuticals.com/role/DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesTables </ParentRole>
<Position> 26 </Position>
</Report>
<Report instance="atnm-20181231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R27.htm </HtmlFileName>
<LongName> 00000027 - Disclosure - Derivative Liabilities (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://actiniumpharmaceuticals.com/role/DerivativeLiabilitiesDetails </Role>
<ShortName> Derivative Liabilities (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://actiniumpharmaceuticals.com/role/DerivativeLiabilitiesTables </ParentRole>
<Position> 27 </Position>
</Report>
<Report instance="atnm-20181231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R28.htm </HtmlFileName>
<LongName> 00000028 - Disclosure - Derivative Liabilities (Details 1) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://actiniumpharmaceuticals.com/role/DerivativeLiabilitiesDetails1 </Role>
<ShortName> Derivative Liabilities (Details 1) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://actiniumpharmaceuticals.com/role/DerivativeLiabilitiesTables </ParentRole>
<Position> 28 </Position>
</Report>
<Report instance="atnm-20181231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R29.htm </HtmlFileName>
<LongName> 00000029 - Disclosure - Derivative Liabilities (Details Textual) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://actiniumpharmaceuticals.com/role/DerivativeLiabilitiesDetailsTextual </Role>
<ShortName> Derivative Liabilities (Details Textual) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://actiniumpharmaceuticals.com/role/DerivativeLiabilitiesTables </ParentRole>
<Position> 29 </Position>
</Report>
<Report instance="atnm-20181231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R30.htm </HtmlFileName>
<LongName> 00000030 - Disclosure - Prepaid Expenses and Other Current Assets (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://actiniumpharmaceuticals.com/role/PrepaidExpensesAndOtherCurrentAssetsDetails </Role>
<ShortName> Prepaid Expenses and Other Current Assets (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://actiniumpharmaceuticals.com/role/PrepaidExpensesAndOtherCurrentAssetsTables </ParentRole>
<Position> 30 </Position>
</Report>
<Report instance="atnm-20181231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R31.htm </HtmlFileName>
<LongName> 00000031 - Disclosure - Prepaid Expenses and Other Current Assets (Details Textual) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://actiniumpharmaceuticals.com/role/PrepaidExpensesAndOtherCurrentAssetsDetailsTextual </Role>
<ShortName> Prepaid Expenses and Other Current Assets (Details Textual) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://actiniumpharmaceuticals.com/role/PrepaidExpensesAndOtherCurrentAssetsTables </ParentRole>
<Position> 31 </Position>
</Report>
<Report instance="atnm-20181231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R32.htm </HtmlFileName>
<LongName> 00000032 - Disclosure - Property and Equipment (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://actiniumpharmaceuticals.com/role/PropertyAndEquipmentDetails </Role>
<ShortName> Property and Equipment (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://actiniumpharmaceuticals.com/role/PropertyAndEquipmentTables </ParentRole>
<Position> 32 </Position>
</Report>
<Report instance="atnm-20181231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R33.htm </HtmlFileName>
<LongName> 00000033 - Disclosure - Property and Equipment (Details 1) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://actiniumpharmaceuticals.com/role/PropertyAndEquipmentDetails1 </Role>
<ShortName> Property and Equipment (Details 1) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://actiniumpharmaceuticals.com/role/PropertyAndEquipmentTables </ParentRole>
<Position> 33 </Position>
</Report>
<Report instance="atnm-20181231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R34.htm </HtmlFileName>
<LongName> 00000034 - Disclosure - Property and Equipment (Details Textual) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://actiniumpharmaceuticals.com/role/PropertyAndEquipmentDetailsTextual </Role>
<ShortName> Property and Equipment (Details Textual) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://actiniumpharmaceuticals.com/role/PropertyAndEquipmentTables </ParentRole>
<Position> 34 </Position>
</Report>
<Report instance="atnm-20181231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R35.htm </HtmlFileName>
<LongName> 00000035 - Disclosure - Commitments and Contingencies (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://actiniumpharmaceuticals.com/role/CommitmentsAndContingenciesDetails </Role>
<ShortName> Commitments and Contingencies (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://actiniumpharmaceuticals.com/role/CommitmentsAndContingenciesTables </ParentRole>
<Position> 35 </Position>
</Report>
<Report instance="atnm-20181231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R36.htm </HtmlFileName>
<LongName> 00000036 - Disclosure - Commitments and Contingencies (Details Textual) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://actiniumpharmaceuticals.com/role/CommitmentsAndContingenciesDetailsTextual </Role>
<ShortName> Commitments and Contingencies (Details Textual) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://actiniumpharmaceuticals.com/role/CommitmentsAndContingenciesTables </ParentRole>
<Position> 36 </Position>
</Report>
<Report instance="atnm-20181231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R37.htm </HtmlFileName>
<LongName> 00000037 - Disclosure - Equity (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://actiniumpharmaceuticals.com/role/EquityDetails </Role>
<ShortName> Equity (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://actiniumpharmaceuticals.com/role/EquityTables </ParentRole>
<Position> 37 </Position>
</Report>
<Report instance="atnm-20181231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R38.htm </HtmlFileName>
<LongName> 00000038 - Disclosure - Equity (Details 1) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://actiniumpharmaceuticals.com/role/EquityDetails1 </Role>
<ShortName> Equity (Details 1) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://actiniumpharmaceuticals.com/role/EquityTables </ParentRole>
<Position> 38 </Position>
</Report>
<Report instance="atnm-20181231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R39.htm </HtmlFileName>
<LongName> 00000039 - Disclosure - Equity (Details Textual) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://actiniumpharmaceuticals.com/role/EquityDetailsTextual </Role>
<ShortName> Equity (Details Textual) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://actiniumpharmaceuticals.com/role/EquityTables </ParentRole>
<Position> 39 </Position>
</Report>
<Report instance="atnm-20181231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R40.htm </HtmlFileName>
<LongName> 00000040 - Disclosure - Income Taxes (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://actiniumpharmaceuticals.com/role/IncomeTaxesDetails </Role>
<ShortName> Income Taxes (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://actiniumpharmaceuticals.com/role/IncomeTaxesTables </ParentRole>
<Position> 40 </Position>
</Report>
<Report instance="atnm-20181231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R41.htm </HtmlFileName>
<LongName> 00000041 - Disclosure - Income Taxes (Details 1) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://actiniumpharmaceuticals.com/role/IncomeTaxesDetails1 </Role>
<ShortName> Income Taxes (Details 1) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://actiniumpharmaceuticals.com/role/IncomeTaxesTables </ParentRole>
<Position> 41 </Position>
</Report>
<Report instance="atnm-20181231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R42.htm </HtmlFileName>
<LongName> 00000042 - Disclosure - Income Taxes (Details Textual) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://actiniumpharmaceuticals.com/role/IncomeTaxesDetailsTextual </Role>
<ShortName> Income Taxes (Details Textual) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://actiniumpharmaceuticals.com/role/IncomeTaxesTables </ParentRole>
<Position> 42 </Position>
</Report>
<Report instance="atnm-20181231.xml">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R43.htm </HtmlFileName>
<LongName> 00000043 - Disclosure - Subsequent Event (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://actiniumpharmaceuticals.com/role/SubsequentEventDetails </Role>
<ShortName> Subsequent Event (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://actiniumpharmaceuticals.com/role/SubsequentEvent </ParentRole>
<Position> 43 </Position>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<LongName> All Reports </LongName>
<ReportType> Book </ReportType>
<ShortName> All Reports </ShortName>
</Report>
</MyReports>
<InputFiles>
<File> atnm-20181231.xml </File>
<File> atnm-20181231.xsd </File>
<File> atnm-20181231_cal.xml </File>
<File> atnm-20181231_def.xml </File>
<File> atnm-20181231_lab.xml </File>
<File> atnm-20181231_pre.xml </File>
</InputFiles>
<SupplementalFiles/>
<BaseTaxonomies>
<BaseTaxonomy> http://fasb.org/us-gaap/2018-01-31 </BaseTaxonomy>
<BaseTaxonomy> http://fasb.org/srt/2018-01-31 </BaseTaxonomy>
<BaseTaxonomy> http://xbrl.sec.gov/dei/2018-01-31 </BaseTaxonomy>
<BaseTaxonomy> http://xbrl.sec.gov/invest/2013-01-31 </BaseTaxonomy>
</BaseTaxonomies>
<HasPresentationLinkbase> true </HasPresentationLinkbase>
<HasCalculationLinkbase> true </HasCalculationLinkbase>
</FilingSummary>

21 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 4/26/24  Actinium Pharmaceuticals, Inc.    10-Q        3/31/24   49:10M                                    EdgarAgents LLC/FA
 3/29/24  Actinium Pharmaceuticals, Inc.    S-8         3/29/24    4:57K                                    EdgarAgents LLC/FA
 3/29/24  Actinium Pharmaceuticals, Inc.    10-K       12/31/23   65:17M                                    EdgarAgents LLC/FA
 2/02/24  Actinium Pharmaceuticals, Inc.    S-3/A                  3:589K                                   EdgarAgents LLC/FA
11/02/23  Actinium Pharmaceuticals, Inc.    10-Q        9/30/23   46:4.2M                                   EdgarAgents LLC/FA
 8/14/23  Actinium Pharmaceuticals, Inc.    10-Q        6/30/23   45:4M                                     EdgarAgents LLC/FA
 8/11/23  Actinium Pharmaceuticals, Inc.    S-3                    4:540K                                   EdgarAgents LLC/FA
 5/15/23  Actinium Pharmaceuticals, Inc.    10-Q        3/31/23   47:5.9M                                   EdgarAgents LLC/FA
 3/31/23  Actinium Pharmaceuticals, Inc.    10-K       12/31/22   60:8.1M                                   EdgarAgents LLC/FA
11/14/22  Actinium Pharmaceuticals, Inc.    10-Q        9/30/22   47:3.4M                                   EdgarAgents LLC/FA
 8/19/22  Actinium Pharmaceuticals, Inc.    S-8         8/19/22    5:185K                                   EdgarAgents LLC/FA
 8/12/22  Actinium Pharmaceuticals, Inc.    10-Q        6/30/22   48:3.7M                                   EdgarAgents LLC/FA
 5/13/22  Actinium Pharmaceuticals, Inc.    10-Q        3/31/22   44:2.7M                                   EdgarAgents LLC/FA
 3/25/22  Actinium Pharmaceuticals, Inc.    10-K       12/31/21   56:4.2M                                   EdgarAgents LLC/FA
11/12/21  Actinium Pharmaceuticals, Inc.    10-Q        9/30/21   42:3.1M                                   EdgarAgents LLC/FA
 7/30/21  Actinium Pharmaceuticals, Inc.    10-Q        6/30/21   44:3.2M                                   EdgarAgents LLC/FA
 5/14/21  Actinium Pharmaceuticals, Inc.    10-Q        3/31/21   43:2.3M                                   EdgarAgents LLC/FA
 3/31/21  Actinium Pharmaceuticals, Inc.    10-K       12/31/20   56:3.5M                                   EdgarAgents LLC/FA
10/23/20  Actinium Pharmaceuticals, Inc.    10-Q        9/30/20   41:2.6M                                   EdgarAgents LLC/FA
 8/14/20  Actinium Pharmaceuticals, Inc.    10-Q        6/30/20   44:2.8M                                   EdgarAgents LLC/FA
 8/07/20  Actinium Pharmaceuticals, Inc.    S-3                    4:702K                                   EdgarAgents LLC/FA
↑Top
Filing Submission 0001213900-19-004269   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help — Tue., May 14, 3:09:51.2pm ET